454 Life Sciences Corporation, subsidiary of CuraGen Corporation, has announced that its Genome Sequencer 20 system has been selected and purchased by Keygene N.V. to enable its proprietary Complexity ...
A study published this month in the journal Tissue Antigens reports that researchers at Roche Molecular Systems in Pleasanton, CA have used high-throughput sequencing technology from 454 Life Sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback